Medicared For All Logo

Sharad Bajaj in Ocala, Florida

Home Florida Ocala

Sharad Bajaj has Cardiovascular Disease (cardiology) as his primary medical specialty. Their primary office is: 2111 Sw 20th Pl in Ocala, Florida. There is an additional office location, for a total of two, for Sharad Bajaj that can be viewed further down.

They're a part of the: Cardiovascular Institute Of Central Florida Llc medical group which has around 51 members. You can call their office at 352-622-4251 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2005 (around 19 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Sharad Bajaj Office Phone and Directions

Sharad Bajaj
Cardiovascular Institute Of Central Florida Llc
2111 Sw 20th Pl
Ocala, Florida 34471
352-622-4251


Patient Ratings
Please rate your experience with Sharad Bajaj below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 352-622-4251


Enter a starting address:


Healthcare Info for Sharad Bajaj

Medical School: Sorry, his university is not listed
Graduation Year: 2005
The Primary Medical Specialty for Sharad Bajaj is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 19
PAC (PECOS ID)#: 2062733751
NPI #: 1497917512
NPI Created On: 06/30/2008
NPI Last Updated Listed as: 07/23/2021
Primary Taxonomy Code: 207RC0000X
License Number:
MD-42371
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Medica Insurance Company
  • Humana
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Radiological supervision and interpretation of imaging of artery of one arm or leg
  2. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
  3. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
  4. Catheter insertion of stents in major coronary artery or branch, accessed through the skin
  5. Insertion of stent, removal of plaque and/or balloon dilation of coronary vessel during heart attack, accessed through the skin
  6. External shock to heart to regulate heart beat
  7. Routine ekg using at least 12 leads including interpretation and report
  8. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
  9. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
  10. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
  11. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
  12. Heart rhythm tracing, analysis, and interpretation of 48-hour ekg
  13. Heart rhythm tracing, analysis, and interpretation of 48-hour ekg
  14. Evaluation of parameters of leadless, single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report
  15. Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days
  16. Remote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days
  17. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  18. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  19. Follow-up or limited ultrasound examination of heart
  20. Follow-up or limited ultrasound examination of heart

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $116

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788320993

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $124

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788320995

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 810922317

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Diabetes

Name of Drug #1: RYBELSUS

Open Associated Drug #1: 0169-4303-13

Drug or Biological: Drug

Product Category #2: Diabetes

Name Of Drug #2:: Ozempic

Associated Drug #2: 0169-4132-12


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 827197399

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Stents

Name of Drug #1: Resolute


Payments Total: $57

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 827197419

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Cardiac Diagnostics and Monitoring

Name of Drug #1: LINQ II


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Informational Meal

Record ID:: 829912117

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular and Metabolism

Name of Drug #1: BRILINTA

Open Associated Drug #1: 0186-0776-60


Additional Office Locations

1. Cardiovascular Institute Of Central Florida Llc
6555 Sw State Rd
Ocala, FL 34476
Suite 200
Group Members: 51

Phone: 352-622-4251

Enter a starting address:


Cardiovascular Disease (cardiology) Professionals in Ocala

2111 Sw 20th Pl
Ocala, FL
Cardiovascular Institute Of Central Florida Llc

2111 Sw 20th Pl
Ocala, FL
Cardiovascular Institute Of Central Florida Llc

3310 Sw 34 St
Ocala, FL
Ocala Heart Clinic Ii Llc

2230 Sw 19th Ave Rd
Ocala, FL
Ocala Family Medical Center Inc

2131 Sw 20th Pl
Ocala, FL
Ocala Family Medical Center Inc

2111 Sw 20th Pl
Ocala, FL
Cardiovascular Institute Of Central Florida Llc

Providers in Cardiovascular Institute Of Central Florida Llc

1.Bosede Afolabi

2111 Sw 20th Pl
Ocala Fl 34471-7734
Cardiovascular Institute Of Central Florida Llc
Cardiac Electrophysiology

2.Illena Antonetti

2111 Sw 20th Pl
Ocala Fl 34471-7734
Cardiovascular Institute Of Central Florida Llc
Cardiovascular Disease (cardiology)

3.Sharad Bajaj

2111 Sw 20th Pl
Ocala Fl 34471-7734
Cardiovascular Institute Of Central Florida Llc
Cardiovascular Disease (cardiology)

4.Sharad Bajaj

6555 Sw State Rd
Ocala Fl 34476-5575
Cardiovascular Institute Of Central Florida Llc
Cardiovascular Disease (cardiology)

5.David Bello Md

2111 Sw 20th Pl
Ocala Fl 34471-7734
Cardiovascular Institute Of Central Florida Llc
Cardiac Electrophysiology

6.Erika Boyd

2111 Sw 20th Pl
Ocala Fl 34471-7734
Cardiovascular Institute Of Central Florida Llc
Nurse Practitioner

View all 51 members of Cardiovascular Institute Of Central Florida Llc medical group